(Q3)Jan 31, 2024 | (Q2)Oct 31, 2023 | (Q1)Jul 31, 2023 | (FY)Apr 30, 2023 | (Q4)Apr 30, 2023 | (Q3)Jan 31, 2023 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -2.59%-323.48K | -3,387.63%-80.91K | -324.16%-142.06K | -453.29K | -94.1K | -11,209.54%-315.31K | -45.06%-2.79K | 80.47%-2.32K | -82.03%-33.49K | 31.16%-34.17K |
Net income from continuing operations | 57.56%-322.28K | -101.13%-93.53K | 10.52%-60.53K | ---1.27M | ---494.54K | -2,646.31%-759.38K | -455.24%-27.65K | -117.81%-46.5K | -412.57%-67.65K | -33.37%-68.2K |
Remuneration paid in stock | ---- | ---- | ---- | --235.55K | ---- | ---- | ---- | ---- | ---- | ---- |
Other non cashItems | ---61.78K | ---- | ---- | --684.66K | --111.41K | ---- | ---- | ---- | ---- | ---- |
Change In working capital | 146.90%60.58K | -61.89%16.84K | -338.63%-81.52K | ---106.47K | --53.48K | -619.54%-129.17K | 713.05%24.86K | 366.46%44.18K | 756.98%34.16K | 2,165.58%34.03K |
-Change in receivables | ---17.54K | ---4.07K | ---5.79K | ---7.67K | ---6.17K | ---- | ---- | ---- | ---- | ---- |
-Change in prepaid assets | --0 | ---2.52K | ---150 | ---4.87K | ---2.63K | ---- | ---- | ---- | ---- | ---- |
-Change in payables and accrued expense | 162.28%78.12K | --23.42K | ---75.58K | --3.57K | --159.78K | ---125.43K | ---- | ---- | ---- | ---- |
-Change in other working capital | ---- | ---- | ---- | ---97.5K | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -2.59%-323.48K | -3,387.63%-80.91K | -324.16%-142.06K | ---453.29K | ---94.1K | -11,209.54%-315.31K | -45.06%-2.79K | 80.47%-2.32K | -82.03%-33.49K | 31.16%-34.17K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -162.32K | -90.12K | ||||||||
Net PPE purchase and sale | ---- | ---- | ---- | ---20K | --0 | ---- | ---- | ---- | ---- | ---- |
Net other investing changes | ---- | ---- | ---- | ---142.32K | ---90.12K | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---- | ---- | ---- | ---162.32K | ---90.12K | ---- | ---- | ---- | ---- | ---- |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | 0 | 0 | 797.99K | 0 | 11,299.43%760K | 6.67K | 0 | 35.6K | |
Net issuance payments of debt | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --35.6K | ---- |
Net other financing activities | ---- | ---- | ---- | --797.99K | --0 | --760K | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --0 | --0 | --0 | --797.99K | --0 | 11,299.43%760K | --6.67K | --0 | --35.6K | ---- |
Net cash flow | ||||||||||
Beginning cash position | -7.83%408.81K | 16,752.06%489.72K | 79,169.51%631.78K | --449.4K | --816.01K | 75,584.98%443.51K | -87.49%586 | -82.46%2.91K | -97.72%797 | -58.67%34.96K |
Current changes in cash | -186.84%-323.48K | -3,387.63%-80.91K | -6,835.75%-142.06K | --182.38K | ---184.23K | 9,502.76%372.49K | 301.82%3.88K | 80.47%-2.32K | 111.46%2.11K | 31.16%-34.17K |
End cash Position | -89.54%85.33K | 69,662.46%408.81K | 16,752.06%489.72K | --631.78K | --631.78K | 18,175.59%816.01K | 61.54%4.47K | -87.49%586 | -82.46%2.91K | -97.72%797 |
Free cash from | 3.53%-323.48K | -3,387.63%-80.91K | -324.16%-142.06K | ---473.29K | ---94.1K | -11,926.90%-335.31K | -45.06%-2.79K | 80.47%-2.32K | -82.03%-33.49K | 31.16%-34.17K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.